The Future of PTSD Diagnosis: How Biomarkers are Revolutionizing Trauma Care
Publish Year: 1403
نوع سند: مقاله کنفرانسی
زبان: English
View: 54
This Paper With 5 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
IRCMMS08_028
تاریخ نمایه سازی: 14 مرداد 1403
Abstract:
The exploration of biomarkers in PTSD diagnosis represents a captivating frontier in trauma
care, underscoring the convergence of translational research and clinical application. Studies
highlight the intricate relationship between biological markers—ranging from genetic and
epigenetic indicators to inflammatory mechanisms and neuroimaging—and PTSD, offering a
glimpse into a future where diagnosis and treatment are profoundly personalized. This body of
work not only emphasizes the complexities inherent in understanding PTSD’s biological
underpinnings but also illuminates the path ahead for integrating biomarkers into practical care.
The potential for these markers to transform diagnosis, prognostication, and treatment underscores
a pivotal shift towards precision medicine in mental health care.
However, the journey from research to clinical practice is fraught with challenges, including the
need for extensive validation and regulatory approval. The field stands at a crucial juncture, with
ongoing studies poised to bridge the gap between promising biomarkers and their application in
diagnosing and treating PTSD. As the research community continues to unravel the molecular and
physiological narratives of PTSD, the hope for more effective, tailored treatment strategies grows.
The significance of these developments extends beyond academia, promising to touch the lives of
those grappling with the aftermath of trauma through more accurate diagnoses and personalized
therapeutic interventions.
Post-Traumatic Stress Disorder (PTSD) stands as a debilitating condition triggered by traumatic
events such as combat and sexual abuse, hallmarked by symptoms like hyperarousal and intrusive
memories[۱][۲]. With PTSD affecting diverse populations, featuring a lifetime prevalence rate of
۶.۸% in the USA, it highlights the urgent need for accurate diagnostic methods[۲].
Biomarkers offer a promising avenue in the evolution of PTSD diagnosis, providing measurable
indicators of biological states that could revolutionize trauma care[۳]. As the field moves towards
precision medicine, the role of biomarkers in detecting and understanding the biological
underpinnings of PTSD is becoming more critical, paving the way for tailored treatment
approaches.
Authors
Negar khaki
medical student of international university
Sogol taher
Cellular and molecular biology stu